Abnormal hCG levels in a patient with treated stage I seminoma: a diagnostic dilemma
2008
Abnormal hCG Levels in a Patient with Treated Stage I Seminoma
Sample size: 1
publication
Evidence: low
Author Information
Author(s): Aherne Noel J, Small Cormac A, McVey Gerard P, Fitzpatrick David A, Armstrong John G
Primary Institution: St. Luke's Hospital, Dublin, Ireland
Conclusion
The case emphasizes the importance of thorough screening for young male patients with a history of testicular germ cell tumors who may use steroids.
Supporting Evidence
- Testicular cancer accounts for 1% of all male cancers.
- The overall 5-year survival rate for testicular cancer is about 99%.
- Routine monitoring of tumor markers like hCG is crucial for patients with testicular cancer.
- Exogenous hCG can lead to false positive results in tumor marker tests.
Takeaway
A bodybuilder had high hCG levels after treatment for testicular cancer because he was using steroids, which could have led to unnecessary treatments.
Methodology
Case report detailing the patient's history, treatment, and follow-up.
Potential Biases
Potential bias due to the patient's withholding of information about steroid use.
Limitations
Only one case is reported, limiting generalizability.
Participant Demographics
26-year-old male bodybuilder.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website